Radiolabelled Peptides: Optimal Candidates for Theranostic Application in Oncology
- Author(s)
- Hall, AJ; Haskali, MB;
- Details
- Publication Year 2022,Volume 75,Issue #2,Page 34-54
- Journal Title
- Australian Journal of Chemistry
- Publication Type
- Review
- Abstract
- Theranostics are drugs suitable for use in both diagnostic and therapeutic applications, and have played an important role in the advancement of modern nuclear medicine. This review explains key elements that are common to successful theranostics and highlights significant developments in the field, including our own. Specific focus is given to peptides and those features that make them most suitable for theranostic application, as well as some key radioisotopes owing to their favourable properties and high clinical utility. This report provides an overview of the techniques at the researcher’s disposal, how they have been applied to current clinically significant targets, and how they might be used and improved upon for future targets.
- Department(s)
- Cancer Imaging
- Publisher's Version
- https://doi.org/10.1071/CH21118
- Open Access at Publisher's Site
https://doi.org/10.1071/CH21118- Terms of Use/Rights Notice
- Refer to copyright notice on published article.
Creation Date: 2024-11-01 04:13:48
Last Modified: 2024-11-01 04:19:47